Tech Advisor: API & Advanced Supply Chain (2-Year)

USP; Rockville (MD); Hybrid; USD 126,000 - 177,000; Full time

Job summary

USP seeks a Technical Advisor for Advanced Supply Chain Solutions in Rockville, MD. This fixed-term, non-laboratory role requires deep expertise in active pharmaceutical ingredients, fine chemicals, and supply chains, plus strong technical writing to deliver risk assessments and actionable recommendations.

The position emphasizes evaluating manufacturing processes, identifying vulnerabilities, and translating findings into practical strategies for essential medicines across donor-funded

Qualifications

• Ph.D. in Organic Chemistry with 2+ years of industrial API or fine chemical experience.
• Demonstrated scientific writing experience and ability to produce technical assessments and reports.
• Experience in evaluating API manufacturing, supply chains, and related technologies.

Responsibilities

• Collect, validate, and analyze chemical, manufacturing, and supply-chain data to identify risks and conclusions.
• Evaluate API and KSM manufacturing processes, sourcing structures, supply-market dynamics, and cost drivers.
• Conduct literature and database reviews to assess processes, routes, suppliers, and technologies.
• Integrate data to assess risks and recommend mitigation options including alternative routes or processes.
• Prepare SOPs, protocols, reports, and project documents.

Skills

Analytical skills

Scientific writing

Communication

Education

Ph.D. in Organic Chemistry with 2+ years API experience

M.Sc. in Organic Chemistry with 5+ years API experience

Job description

USP seeks a Technical Advisor for Advanced Supply Chain Solutions in Rockville, MD. This fixed-term, non-laboratory role requires deep expertise in active pharmaceutical ingredients, fine chemicals, and supply chains, plus strong technical writing to deliver risk assessments and actionable recommendations.

The position emphasizes evaluating manufacturing processes, identifying vulnerabilities, and translating findings into practical strategies for essential medicines across donor-funded